{
Shilpa Medicare Limited

Companies

}
Shilpa Medicare Zydus JV receives USFDA approval for innovative cancer treatment solution
Shilpa Medicare's joint venture with Zydus, Oncosol, has received USFDA approval for IMKELDI, the first oral liquid formulation of imatinib for certain cancers. This innovative delivery system aims to improve patient adherence and dosing precision, particularly for those who struggle with swallowing. The company reported a significant rise in net profit and revenue for the September quarter, marking eight consecutive quarters of EBITDA improvement.
Moneycontrol
United States Dollar Shilpa Medicare Limited Shorla Oncology Zydus IND Sharon Cunningham Show more
Healthcare, Press Release
11:17 27.11.2024
trading insights for ashok leyland dlf hfcl nalco and shilpa medicare
On Friday, traders are advised to consider strategies for stocks including Ashok Leyland, DLF, HFCL, NALCO, Shilpa Medicare, and CDSL. Additionally, there is an option to receive push notifications for relevant content and transaction updates.
Moneycontrol
DLF CDSL HFCL Limited Ashok Leyland Limited NALCO Shilpa Medicare Limited IND Show more
Finance & Economy, Market Report
21:02 21.11.2024
Shilpa Medicare shares surge after receiving key European quality certifications
Shilpa Medicare shares surged over 6% following the approval of two Certificates of Suitability (CEP) from the EDQM for its subsidiary, Shilpa Pharma Lifesciences. The stock has skyrocketed 180% year-to-date, significantly outperforming the Nifty 50"s 9% gain. The first CEP, for Octreotide, aids in treating acromegaly and related conditions, while the second, for Nifedipine, is used to manage hypertension and angina.
Moneycontrol
Indian Rupee Shilpa Medicare Limited IND
Finance & Economy, Market Report
08:58 19.11.2024
tocks to watch medplus health godavari biorefineries and more
Medplus Health, PG Electroplast, Shilpa Medicare, Themis Medicare, and Waaree Energies are set to be in focus on Tuesday due to significant market activities. In quarterly earnings, Godavari Biorefineries reported a widened loss of Rs 75 crore for Q2, compared to a loss of Rs 65.1 crore in the previous year.
Moneycontrol
PG Electroplast Limited Themis Medicare Limited MedPlus Health Services Limited Shilpa Medicare Limited Waaree Energies Limited IND Show more
Finance & Economy, Market Report
22:31 18.11.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Central Bank Actions Market Sentiment Analysis Corporate Responsibility & ESG Banking Regulations Decentralized Finance (DeFi) Innovations Cryptocurrency & Blockchain Regulations Inflation Rates & CPI Data Tokenomics and Crypto Economics Cryptocurrency Regulations Mergers & Acquisitions Anti-Money Laundering (AML) Regulations Market Analysis and Predictions Hedge Funds & Private Equity SEC & Financial Compliance Blockchain Technology Adoption ESG & Sustainable Finance Regulations Cryptocurrency Developments
Countries:
USA CHE JPN CHN DEU AUS IND KOR HKG SGP TWN THA GBR RUS CAN FRA AUT BRA SAU IDN
Companies:
Ripples USD Solana USD Credit Suisse Real Estate Fund Siat Apple Inc. BlackRock, Inc. Coinbase Global, Inc. MicroStrategy Incorporated NVIDIA Corporation Ethereum USD Tesla, Inc. Cardano USD Volkswagen AG Hon Hai Precision Industry Co., Ltd. Google Inc. Bitwise Bitcoin ETF Chainlink USD Amazon.com, Inc. MicroStrategy Inc Tether USDt CNY Kraken Energy Corp.
Currencies:
United States Dollar Euro Swiss Franc Japanese Yen Australian Dollar Chinese Yuan South Korean Won Singapore Dollar Canadian Dollar Colombian Peso Indian Rupee Hong Kong Dollar Seychellois Rupee Philippine Peso Malaysian Ringgit
People:
Donald Trump Ali Martinez Elon Musk Jerome Powell Michael J. Saylor Paul Atkins Gary Gensler David O. Sacks Charles Hoskinson Wiley Nickel Joe Biden Sriram Krishnan Bo Hines Karin Keller-Sutter Bill Gates Fred Thiel Jack Dorsey Jacob King Brian Armstrong Aaron Green

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.